title: Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells: low-dose ifosfamide and local tumor irradiation.
authors.affiliation: Department of Surgery, University of Heidelberg, Germany.
authors.forename: Eduard
authors.initials: E
authors.lastname: Ryschich
authors.forename: Ralf
authors.initials: R
authors.lastname: Jesnowski
authors.forename: Jörg
authors.initials: J
authors.lastname: Ringel
authors.forename: Walter
authors.initials: W
authors.lastname: Harms
authors.forename: Oliver V
authors.initials: OV
authors.lastname: Fabian
authors.forename: Robert
authors.initials: R
authors.lastname: Saller
authors.forename: Michael
authors.initials: M
authors.lastname: Schrewe
authors.forename: Alexander
authors.initials: A
authors.lastname: Engel
authors.forename: Jan
authors.initials: J
authors.lastname: Schmidt
authors.forename: Matthias
authors.initials: M
authors.lastname: Löhr
mesh_terms: D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D049109:Cell Proliferation / Q000187:drug effects / Q000528:radiation effects; D003131:Combined Modality Therapy; D019362:Cytochrome P-450 CYP2B1 / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004339:Drug Compounding; D007069:Ifosfamide / Q000627:therapeutic use*; D008214:Lymphocytes / Q000187:drug effects / Q000528:radiation effects; D008297:Male; D008833:Microcirculation; D010190:Pancreatic Neoplasms / Q000378:metabolism / Q000628:therapy*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D011829:Radiation Dosage; D051381:Rats; D011917:Rats, Inbred Lew; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D018906:Antineoplastic Agents, Alkylating; D018809:Proliferating Cell Nuclear Antigen; D014409:Tumor Necrosis Factor-alpha; D019362:Cytochrome P-450 CYP2B1; D007069:Ifosfamide